The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.

about

Multiscale technologies for treatment of ischemic cardiomyopathy.Circulating Exosomes in Cardiovascular Diseases.

P2860

Q46454164-DD393D85-0627-4A0F-9330-96B0E238449B Q48653724-BACA037C-F462-4762-9C8B-3229B10519A0

P2860

The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.

Item

http://www.wikidata.org/entity/Q38775962

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The potential for nanotechnolo ...... y to the acute ischemic heart.

@en

type

Item

label

The potential for nanotechnolo ...... y to the acute ischemic heart.

@en

prefLabel

The potential for nanotechnolo ...... y to the acute ischemic heart.

@en

P1476

The potential for nanotechnolo ...... y to the acute ischemic heart.

@en

P2093

K Swaminathan Iyer

http://www.w3.org/2001/XMLSchema#string

P2860

Smart nanosystems: Bio-inspired technologies that interact with the host environment

A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model

Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria

Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway.

Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction.

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts.

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.

Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.

Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor

P304

817-832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.16.7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cameron W. Evans

Livia C Hool

P577

2016-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26980180

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology

The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.

about

P2860

P2860

The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921